Some social media users have been saying that Merck’s experimental COVID-19 antiviral product molnupiravir is a rebranded version of the anti-parasitic Ivermectin. Two disease experts have told ...

WASHINGTON — Editor's Note: In a previous version of this story and the video above, the term 'mRNA viruses' was used instead of 'RNA viruses.' The story has been corrected. Pharmaceutical company ...

Social media users have falsely claimed Merck’s newly UK-approved COVID-19 antiviral product is a repackaged version of the anti-parasitic drug ivermectin. Two disease experts have previously told ...

Imagine if you were in the hospital with a life-threatening yet treatable illness. Your doctor enters the room with four vials: the first three contain drugs that have been tested many times, and ...

Endorsing COVID-19 vaccine misinformation, lack of trust in physicians or scientists, and conspiracy-mindedness were linked to the use of non-evidence-based treatments for COVID-19, an internet-based ...

A new study suggests that the antiviral Molnupiravir may “paradoxically” be driving COVID-19 mutations, creating variants of concern. What is going on? It is all about molnupiravir’s mode of action ...

Medical experts have repeatedly debunked claims that ivermectin, an anti-parasitic drug used primarily for farm animals, can treat COVID-19. Nevertheless, the assertion that ivermectin is an effective ...

Yesterday I wrote about the potential dangers the antiviral drug molnupiravir could unleash by supercharging new SARS-CoV-2 variants. Today, my focus is on the people who may receive the drug as a ...